“What remains in diseases after the crisis is apt to produce relapses.” ― Hippocrates Our SUD evidence base tends to be myopic and crisis oriented. It is focused on first aid and short-term stabilization rather than on developing sustained recovery over time. Nowhere is this more evident than in our response to emerging drug combinations … Continue reading Will We Ever Move Beyond an Acute Crisis Orientation? The Absence of Recovery Research and Emerging Drugs
Tag: xylazine
The Tragic & Predictable Known Unknown Challenges of Medetomidine and Xylazine – William Stauffer
Medetomidine and Xylazine have been in our drug supply for years, but their use is becoming increasingly prevalent on streets across America. They are typically being mixed with short acting opioids, primarily Fentanyl in order to enhance the synergistic effects. For readers, this is two plus two equals eight as anyone who ever had a … Continue reading The Tragic & Predictable Known Unknown Challenges of Medetomidine and Xylazine – William Stauffer
